The role of programmed cell death as an emerging new concept for the pathogenesis of autoimmune diseases

Clinical Immunology and Immunopathology

Volumn 80, Issue 3 II, 1996, Pages

  Mountz, John Douglas ^a,b   Zhou, Tong ^a   Su, Xiao ^a   Wu, Jianguo ^a   Cheng, Jianhua ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b LHRB 473 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN; PROTEIN BCL 2; PROTEIN P53; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; AUTOIMMUNITY; CONFERENCE PAPER; ETIOLOGY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL;

EID: 0029815759     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0136     Document Type: Conference Paper

References (103)

1. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R., Cell death: The significance of apoptosis. Int. Rev. Cytol. 68, 251-306, 1980.
2. Steller, H., Mechanisms and genes of cellular suicide. Science 267, 1445-1449, 1995.
3. Duke, R. C., Chervenak, R., and Cohen, J. J., Endogenous endonuclease-induced DNA fragmentation: An early event in cell-mediated cytolysis. Proc. Natl. Acad. Sci. USA 80, 6361-6365, 1983.
4. Schmid, D. S., Tite, J. P., and Ruddle, N. H., DNA fragmentation: Manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant. Proc. Natl. Acad. Sci. USA 83, 1881-1885, 1986.
5. Green, D. R., and Scott, D. W., Activation-induced apoptosis in lymphocytes. Curr. Opin. Immunol. 6, 476-487, 1994.
6. Nagata, S., and Golstein, P., The fas death factor. Science 267, 1449-1456, 1995.
7. Golstein, P., Ojcius, D. M., and Young, J. D., Cell death mechanisms and the immune system. Immunol. Rev. 121, 29-65, 1991.
8. Cohen, J. J., Duke, R. C., Fadok, V. A., and Sellins, K. S., Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10, 267-293, 1992.
9. Ucker, D. S., Cytotoxic T lymphocytes and glucocorticoids activate an endogenous suicide process in target cells. Nature 327, 62-64, 1987.
10. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H., and Golstein, P., Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity. Science 265, 528-530, 1994.
11. 2+ in toxic cell killing. Trends Pharmacol. Sci. 10, 281-285, 1989.
12. Arends, M. J., Morris, R. G., and Wyllie, A. H., Apoptosis: The role of the endonuclease. Am. J. Pathol. 136, 593-608, 1990.
13. Knight, C. R., Rees, R. C., and Griffin, M., Apoptosis: A potential role for cytosolic transglutaminase and its importance in tumor progression. Biochem. Biophys. Acta 1096, 312-318, 1991.
14. Jacobson, M. D., Burne, J. F., and Raff, M. C., Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13, 1899-1910, 1994.
15. Dheln, J., Walczak, H., Baumler, C., Debatin, K-M., and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1/(Fas/ CD95). Nature 373, 438-441, 1995.
16. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Manboubl, A., Echeverre, F., Martin, J., Force, W. R., Lynch, D. H., Ware, C. F., and Green, D. R., Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-444, 1995.
17. Ju, S-T., Panka, D. J., Cul, H., Ettinger, R., El-Khatib, M., Sherr, D. H., Stanger, B. Z., and Marshak-Rothestein, A., Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-447, 1995.
18. Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A., and Nagata, S., The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J. Immunol. 125, 871-876, 1992.
19. Adachi, M., Watanabe-Fukunaga, R., and Nagata, S., Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90, 1756-1761, 1993.
20. Wu, J., Zhou, T., He, J., and Mountz, J. D., Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178, 461-468, 1993.
21. Chu, J-L., Drappa, J., Parnassa, A., and Elkon, K. B., The defect of Fas mRNA expression in MRL-lpr mice is associated with insertion of the retrotransposon, ETn. J. Exp. Med. 178, 723-730, 1993.
22. Wu, J., Zhou, T., Zhang, J., and Mountz, J. D., Correction of autoimmune disease in CD2-fas transgenic mice. Proc. Natl. Acad. Sci. USA 91, 2344-2348, 1994.
23. Mountz, J. D., Zhou, T., Wu, J., Wang, W., and Cheng, J., Regulation of apoptosis in immune cells. Special Article. J. Clin. Immunol. 15, 1-16, 1995.
24. Suda, T., Takahashi, T., Golstein, P., and Nagata, S., Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178, 1993.
25. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976, 1994.
26. Lynch, D., Watson, M., Alderson, M. R., Baum, P. R., Miller, R. E., Tough, T., Gibson, M., Davis-Smith, T., Smith, C. A., Hunter, K., Bhat, D., Din, W., Goodwin, R. G., and Seldin, M. F., The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1, 131-136, 1994.
27. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Aral, N., Ozaki, S., Nakao, K., and Nagata, S., Expression of the fas ligand in cells of T-cell lineage. J. Immunol. 154, 3806-3813, 1995.
28. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91, 4185-4189, 1994.
29. Cheng, J., Liu, C., Koopman, W. J., and Mountz, J. D., Characterization of human Fas gene. Exon/intron organization and promoter region. J. Immunol. 154, 1239-1245, 1995.
30. Behrmann, I., Walczak, H., and Krammer, P. H., Structure of the human APO-1 gene. Eur. J. Immunol. 24, 3057-3062, 1994.
31. Rothe, M., Wong, S. C., Henzel, W. J., and Goeddel, D. V., A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692, 1994.
32. Tartaglia, L. A., Rothe, M., Hu, Y. F., and Goeddel, D. V., Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73, 213-216, 1993.
33. Itoh, N., and Nagata, S., A novel protein domain required for apoptosis: Mutational analysis of human Fas antigen. J. Biol. Chem. 268, 10932-10937, 1993.
34. Walker, P. R., Kwast-Welfeld, J., Gourdeau, H., Leblanc, J., Neugebauer, W., and Sikorska, M., Relationship between apoptosis and the cell cycle in lymphocytes: Roles of protein kinase C, tyrosine phosphorylation, and AP1. Exp. Cell Res. 207, 142-151, 1993.
35. Seldin, M. F., Mountz, J. D., Mushinski, J. F., Smith, H. R., and Steinberg, A. D., IL-2 modulation of murine T-cell oncogene expression. Proc. Soc. Exp. Biol. Med. 184, 186-190, 1987.
36. Mountz, J. D., and Steinberg, A. D., Studies of c-myb gene regulation in MRL-lpr/lpr mice: Identification of the 5′ c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells. J. Immunol. 142, 328-335, 1989.
37. Mountz, J. D., Steinberg, A. D., Klinman, D. M., Smith, H. R., and Mushinski, J. F., Autoimmunity and increased c-myb transcription. Science 226, 1087-1089, 1984.
38. Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., and Mountz, J. D., Protection from Fasmediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759-1762, 1994.
39. Gmelig-Meyling, F., Dawisha, S., and Steinberg, A. D., Assessment of in vivo frequency of mutated T cells in patients with systemic lupus erythematosus. J. Exp. Med. 175, 297-300, 1992.
40. Liu, C., Cheng, J., and Mountz, J. D., Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem. J. 310, 957-963, 1995.
41. Tan, E. M., Chan, E. K. L., Sullivan, K. F., and Rubin, R. L., Antinuclear antibodies (ANAs): Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin. Immunol. Immunopathol. 47, 121-126, 1988.
42. Guthrie, C., Messenger RNA splicing in yeast: Clue to why the splicesome is a ribonucleoprotein. Science 253, 157-163, 1991.
43. Ruby, S. W., and Abelson, J., Pre-mRNA splicing in yeast. Trends Genet. 7, 79-83, 1991.
44. Tan, C.-K., Sullivan, K., Li, X., Tan, E. M., Downey, K., and So, A. G., Autoantibody to the proliferating cell nuclear antigen neutralizes that activity of the auxiliary protein for DNA polymerase delta. Nucleic Acids Res. 15, 9229-9235, 1987.
45. Dang, C. V., Tan, E. M., and Traugh, J. A., Myositis autoantibody reactivity recognized by murine monoclonal antibodies. J. Exp. Med. 166, 1627-1630, 1988.
46. Takano, Y., Okudaira, M., and Harmon, B. V., Apoptosis is induced by microtubule disrupting drugs in cultured human lymphoma cells: Inhibitory effects of phorbol ester and zinc sulphate. Pathol. Res. Practice 189, 197-203, 1993.
47. Illera, V. A., Perandones, C. E., Stunz, L. L., Mower, D. A., Jr., and Ashman, R. F., Apoptosis in splenic B lymphocytes: Regulation by protein kinase C and IL-4. J. Immunol. 151, 2965-2973, 1993.
48. Forbes, I. J., Zalewski, P. D., Giannakis, C., and Cowled, P. A., Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp. Cell Res. 198, 367-372, 1992.
49. Baxter, G. D., and Lavin, M. F., Specific protein dephosphorylation in apoptosis induced by ionizing radiation and heat shock in human lymphoid tumor lines. J. Immunol. 148, 1949-1954, 1992.
50. Song, Q., and Lavin, M. F., Calyculin A, a potent inhibitor of phosphatase-1 and -2A, prevents apoptosis. Biochem. Biophys. Res. Commun. 190, 47-55, 1993.
51. Fruman, D. A., Mather, P. E., Burakoff, S. J., and Bierer, B. E., Correlation of calcineurin phosphatase activity and programmed cell death in murine T-cell hybridomas. Eur. J. Immunol. 22, 2513-2517, 1992.
52. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., and Nagata, S., The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243, 1991.
53. Yonehara, S., Ishii, A., and Yonehara, M., A cell-killing mAb (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756, 1989.
54. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., Trauth, B. C., Ponstingl, H., and Krammer, P. H., Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor family. J. Biol. Chem. 267, 10709-10715, 1989.
55. Trauth, B. C, Klas, C., Peters, A. M. J., Matzuku, S., Moller, P., Falk, W., Debatin, K.-M., and Krammer, P. H., MAb-mediated tumor regression by induction of apoptosis. Science 245, 301-305, 1989.
56. Sato, T., Irie, S., Kitada, S., and Reed, J. C., FAP-1: A protein tyrosine phosphatase that associates with fas. Science 268, 411-415, 1995.
57. Su, X., Zhou, T., Wang, Z., Yang, P., Jope, R. S., and Mountz, J. D., Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 2, 353-362, 1995.
58. Yi, T., Cleveland, J. L., and Ihle, J. N., Protein tyrosine phosphatase containing SH2 domains: Characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol. Cell. Biol. 12, 836-846, 1992.
59. Shen, S.-H., Bastien, L., Posner, B. I., and Chretien, P., A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 352, 736-739, 1991.
60. Zhao, Z., Bouchard, P., Diltz, C. D., Shen, S.-H., and Fischer, E. H., Purification and characterization of a protein tyrosine phosphatase containing SH2 domains. J. Biol. Chem. 268, 2816-2820, 1993.
61. Matthews, R. J., Bowne, D. B., Flores, E., and Thomas, M. L., Characterization of hematopoietic intracellular protein tyrosine phosphatases: Description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol. Cell. Biol. 12, 2396-2405, 1992.
62. Plutzky, J., Neel, B. G., and Rosenberg, R. D., Isolation of an src homology 2-containing tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 89, 1123-1127, 1992.
63. Plutzky, J., Neel, B. G., Rosenberg, R. D., Eddy, R. L., Byers, M. G., Jani-Sait, S., and Shows, T. B., Chromosomal localization of an SH2-containing tyrosine phosphatase (PTPN6). Genomics 13, 869-872, 1992.
64. Shultz, L. D., Schweitzer, P. A., Rajan, T. V., Yi, T., Ihle, J. N., Matthews, R. J., Thomas, M. L., and Beier, D. R., Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73, 1445-1454, 1993.
65. Tsui, H. W., Siminovitch, K. A., de Souza, L., and Tsui, F. W., Motheaten and viable motheaten mice have mutations in the hematopoietic cell phosphatase gene. Nature Genet. 4, 124-129, 1993.
66. Sidman, C. L., Marshall, J. D., and Allen, R. D., Murine "viable motheaten" mutation reveals a gene critical to the development of both B and T lymphocytes. Proc. Natl. Acad. Sci. USA 86, 6279-6282, 1989.
67. Green, M. C., and Shultz, L. D., Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology. J. Hered. 66, 250-258, 1975.
68. Shultz, L. D., Pleiotropic effects of deleterious alleles at the "motheaten" locus. Curr. Top. Microbiol. Immunol. 137, 216-222, 1988.
69. Shultz, L. D., Coman, D. R., Bailey, C. L., Beamer, W. G., and Sidman, C. L. "Viable motheaten": A new allele at the motheaten locus. I. Pathology. Am. J. Pathol. 116, 179-192, 1984.
70. Shultz, L. D., Hematopoiesis and models of immunodeficiency. Semin. Immunol. 3, 397-408, 1991.
71. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S., Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809, 1993.
72. Cifone, M. G., De Maria, R., Roncaioli, P., Rippo, M. R., Azuma, M., Lanier, L. L., Santoni, A., and Testi, R., Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 180, 1547-1552, 1994.
73. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K, Ramsdell, F., and Lynch, D. L., Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178, 2231-2235, 1993.
74. Cohen, P. L., and Eisenberg, R. A., Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243-265, 1991.
75. Samelson, L. E., Davidson, W. F., Morse, M. C., III, and Klausner, R. D., Abnormal tyrosine phosphorylation of T-cell receptor in lymphoproliferative disorders. Nature 324, 674-676, 1986.
76. - T cells in lpr mice. J. Immunol. 148, 1055-1064, 1992.
77. v) mice is associated with a loss of intrathymic precursor activity. Dev. Immunol. 2, 191-205, 1992.
78. Lucas, B., Vasseur, F., and Penit, C., Production, selection, and maturation of thymocytes with high surface density of TCR. J. Immunol. 153, 53-58, 1994.
79. + thymocytes by T-cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J. Exp. Med. 179, 709-713, 1994.
80. + thymocytes. J. Immunol. 151, 1868-1880, 1993.
81. + T cells in MRL-lpr/lpr mice. Clues from a T-cell receptor beta transgenic mouse. J. Immunol. 150, 3651-3667, 1993.
82. Zhou, T., Bluethmann, H., Eldridge, J., Berry, K., and Mountz, J. D., Abnormal thymocyte development and production of autoreactive T cells in TCR transgenic autoimmune mice. J. Immunol. 147, 466-474, 1991.
83. Zhou, T., Mountz, J. D., Edwards, C. K., III, Berry, K., and Bluethmann, H., Defective maintenance of T-cell tolerance to a superantigen in MRL-lpr/lpr. J. Exp. Med. 176, 1063-1072, 1992.
84. Mountz, J. D., Zhou, T., Bluethmann, H., Wu, J., and Edwards, C. K., Ill, Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice. Int. Rev. Immunol. 11, 321-342, 1994.
85. Bissonnette, R. P., Echeverri, F., Mahboubi, A., and Green, D. R., Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359, 552-554, 1992.
86. Fanidi, A., Harrington, E. A., and Evan, G. I., Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359, 554-556, 1992.
87. Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bissonnette, R. P., and Green, D. R., Role for c-myc in activation-induced apoptotic cell death in T-cell hybridomas. Science 257, 212-214, 1992.
88. Strasser, A., Harris, A. W., and Cory, S., Bcl-2 transgene inhibits T-cell death and perturbs thymic self-censorship. Cell 67, 889-899, 1991.
89. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H., Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-852, 1993.
90. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T., p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-849, 1993.
91. Lee, J. M., and Bernstein, A., p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA 90, 5742-5746, 1993.
92. Williams, G. T., and Lau, L. F., Activation of the inducible orphan receptor gene nur77 by serum growth factors: Dissociation of immediate-early and delayed-early responses. Mol. Cell. Biol. 13, 6124-6136, 1993.
93. Abu-Shakra, S. R., Cole, A. J., and Drachman, D. B., Nerve stimulation and denervation induce differential patterns of immediate early gene mRNA expression in skeletal muscle. Brain Res. Mol. Brain Res. 18, 216-220, 1993.
94. Gubits, R. M., Burke, R. E., Casey-McIntosh, G., Bandele, A., and Munell, F., Immediate early gene induction after neonatal hypoxia-ischemia. Brain Res. Mol. Brain Res. 18, 228-238, 1993.
95. Mittelstadt, P. R., and DeFranco, A. L., Induction of early response genes by cross-linking membrane Ig on B lymphocytes. J. Immunol. 150, 4822-4832, 1993.
96. Davis, I. J., Hazel, T. G., Chen, R. H., Blenis, J., and Lau, L. F., Functional domains and phosphorylation of the orphan receptor Nur77. Mol. Endocrinol. 7, 953-964, 1993.
97. Yoon, J. K., and Lau, L. F., Transcriptional activation of the inducible nuclear receptor gene nur77 by nerve growth factor and membrane depolarization in PC12 cells. J. Biol. Chem. 268, 9148-9155, 1993.
98. Scearce, L. M., Laz, T. M., Hazel, T. G., Lau, L. F., and Taub, R., RNR-1, a nuclear receptor in the NGFI-B/Nur77 family that is rapidly induced in regenerating liver. J. Biol. Chem. 268, 8855-8861, 1993.
99. Rangnekar, V. V., Waheed, S., and Rangnekar, V. M., Interleukin-1-inducible tumor growth arrest is characterized by activation of cell type-specific "early" gene expression programs. J. Biol. Chem. 267, 6240-6248, 1992.
100. Law, S. W., Conneely, O. M., DeMayo, F. J., and O'Malley, B. W., Identification of a new brain-specific transcription factor, NURR1. Mol. Endocrinol. 6, 2129-2135, 1992.
101. Liu, Z.-G., Smith, S. W., McLaughlin, K. A., Schwartz, L. M., and Osborne, B. A., Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene Nur77. Nature 367, 281-284, 1994.
102. Woronica, J. D., Cainan, B., Ngo, V., and Winoto, A., Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367, 277-280, 1994.
103. Franklin, R. A., Tordai, A., Patel, H., Gardner, A. M., Johnson, G. L., and Gelfand, E. W., Ligation of the T-cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes. J. Clin. Invest. 93, 2134-2140, 1994.